ES2061563T3 - TREATMENT AGENTS FOR KIDNEY DISEASES. - Google Patents

TREATMENT AGENTS FOR KIDNEY DISEASES.

Info

Publication number
ES2061563T3
ES2061563T3 ES88109227T ES88109227T ES2061563T3 ES 2061563 T3 ES2061563 T3 ES 2061563T3 ES 88109227 T ES88109227 T ES 88109227T ES 88109227 T ES88109227 T ES 88109227T ES 2061563 T3 ES2061563 T3 ES 2061563T3
Authority
ES
Spain
Prior art keywords
treatment agents
kidney diseases
imidazolylmethyl
tetrahydronaphthalene
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88109227T
Other languages
Spanish (es)
Inventor
Hidemi Daiichi Seiyak Masumura
Kiyoshi Daiichi Seiyaku R Irie
Shinichiro Daiichi Seiy Ashida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2061563T3 publication Critical patent/ES2061563T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to the use of 6-(1-imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical composition for preventing and treating renal diseases.
ES88109227T 1987-06-10 1988-06-09 TREATMENT AGENTS FOR KIDNEY DISEASES. Expired - Lifetime ES2061563T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14477987 1987-06-10

Publications (1)

Publication Number Publication Date
ES2061563T3 true ES2061563T3 (en) 1994-12-16

Family

ID=15370238

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88109227T Expired - Lifetime ES2061563T3 (en) 1987-06-10 1988-06-09 TREATMENT AGENTS FOR KIDNEY DISEASES.

Country Status (11)

Country Link
EP (1) EP0294814B1 (en)
KR (1) KR960007751B1 (en)
AT (1) ATE99933T1 (en)
AU (1) AU609141B2 (en)
CA (1) CA1310908C (en)
DE (1) DE3887005T2 (en)
DK (1) DK312888A (en)
ES (1) ES2061563T3 (en)
IL (1) IL86647A (en)
PH (1) PH25092A (en)
ZA (1) ZA884053B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative

Also Published As

Publication number Publication date
CA1310908C (en) 1992-12-01
IL86647A (en) 1992-02-16
DE3887005D1 (en) 1994-02-24
AU1753188A (en) 1988-12-15
EP0294814B1 (en) 1994-01-12
PH25092A (en) 1991-02-19
ATE99933T1 (en) 1994-01-15
KR960007751B1 (en) 1996-06-12
KR890000089A (en) 1989-03-11
AU609141B2 (en) 1991-04-26
EP0294814A2 (en) 1988-12-14
DK312888A (en) 1988-12-11
DE3887005T2 (en) 1994-05-11
DK312888D0 (en) 1988-06-09
ZA884053B (en) 1989-02-22
IL86647A0 (en) 1988-11-30
EP0294814A3 (en) 1990-09-19

Similar Documents

Publication Publication Date Title
MA23170A1 (en) PROCESS FOR THE PREPARATION OF A NEW COMPOUND.
DE3382458D1 (en) HAIR GROWTH AGENT.
EP0509317A3 (en) Use of droloxifene in the treatment of bone diseases
EP0285008A3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
MA21682A1 (en) PROCESS FOR THE PREPARATION OF THERAPEUTIC AGENTS DERIVED FROM QUAINCLIDINE.
IT8320301A0 (en) LIQUID PREPARATIONS OF DIHYDROPYRIDINES, PROCEDURE FOR THEIR PREPARATION AS WELL AS THEIR USE IN THE TREATMENT OF DISEASES.
IT8322855A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE.
DK0501705T3 (en) Use of tomoxetine for the treatment of diseases of the lower urinary tract
DE69521536D1 (en) Compositions containing G-CSF and a TNF binding protein
MY104006A (en) 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases.
RU94011321A (en) METHOD OF PREVENTION AND TREATMENT OF SKIN DISEASES
ES2061563T3 (en) TREATMENT AGENTS FOR KIDNEY DISEASES.
IT1223395B (en) CARDIOVASCULAR ACTIVITY COMPOUNDS
ATE147978T1 (en) USE OF (E)-2-(P-FLUOROPHENETHYL)-3-FLUOROALLYLAMINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
WO1986006960A3 (en) Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
ATE67931T1 (en) BUTYLHYDROXYANISOLS FOR THE TREATMENT OF RETROVIRUS DISEASES.
ATE49958T1 (en) PHARMACEUTICAL COMPOSITIONS WITH IMMUNODEPRESSANT ACTIVITIES.
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
IT8147600A0 (en) L-ALANINE AS A PHARMACEUTICAL AGENT USED FOR THE TREATMENT OF VASCULAR CEREBROPATHIES AND RELATED FORMULATIONS
IT8819879A0 (en) PHARMACEUTICAL COMPOSITIONS SUITABLE FOR USE IN THE THERAPY OF ARTERIAL HYPOTENSION.
IT7945204A0 (en) PHARMACEUTICAL COMPOSITION FOR THE THERAPY OF MALE STERILITY

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 294814

Country of ref document: ES